ASHCROFT SURGERY
NEWLANDS WAY, ECCLESHILL, BRADFORD
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 17 | 20 | 85.0% | |
| HF 4 | 2011 | 15 | 24 | 62.5% | |
| HF 4 | 2012 | 19 | 25 | 76.0% | |
| HF 4 | 2013 | 15 | 15 | 100.0% | |
| HF004 | 2014 | 9 | 9 | 100.0% | |
| HF004 | 2015 | 20 | 21 | 95.2% | |
| HF004 | 2016 | 19 | 19 | 100.0% | |
| HF004 | 2017 | 18 | 18 | 100.0% | |
| HF004 | 2018 | 17 | 22 | 77.3% | |
| HF004 | 2019 | 16 | 20 | 80.0% | |
| HF004 | 2020 | 22 | 27 | 81.5% | |
| HF006 | 2021 | 25 | 34 | 73.5% | |
| HF006 | 2022 | 30 | 33 | 90.9% | |
| HF006 | 2023 | 53 | 53 | 100.0% |
